Polymer Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Polymer Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,441	Closed	-$354K	–	826
2025 Q4	$354K	Buy	+16,441	New	+$319K	0.04%	581

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Polymer Capital Management's AVDL Position: Q1 2026 in Review

Polymer Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 16,441 shares — an estimated $354K sold.

Polymer Capital Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $354K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Polymer Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Polymer Capital Management sold 16,441 Avadel Pharmaceuticals shares in Q1 2026, an estimated $354K.
Polymer Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Polymer Capital Management's Avadel Pharmaceuticals position peaked at $354K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Polymer Capital Management's 13F filing for Q1 2026, filed 14 May 2026.